| Lastest Insider Transactions Of BeOne Medicines Ltd. ( ONC ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2026-03-11 | Sell | 341 | 300.00 | 102,300 | 2026-03-13 17:26:09 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2026-03-11 | Option Exercise | 341 | 191.64 | 65,348 | 2026-03-13 17:26:09 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2026-02-04 | Sell | 1,660 | 349.52 | 580,197 | 2026-02-06 16:57:20 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2026-02-04 | Option Exercise | 1,660 | 191.40 | 317,721 | 2026-02-06 16:57:20 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2026-01-07 | Sell | 664 | 331.76 | 220,289 | 2026-01-09 17:15:55 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2026-01-07 | Option Exercise | 664 | 191.56 | 127,196 | 2026-01-09 17:15:55 |
| ONC | BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer | 2025-12-15 | Sell | 100,000 | 306.59 | 30,659,418 | 2025-12-17 16:47:31 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-12-10 | Sell | 664 | 321.64 | 213,569 | 2025-12-12 16:56:21 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-12-10 | Option Exercise | 664 | 191.56 | 127,196 | 2025-12-12 16:56:21 |
| ONC | BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. | Directior | 2025-11-26 | Sell | 2,627 | 340.90 | 895,534 | 2025-12-01 16:57:56 |
| ONC | BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. | Directior | 2025-11-26 | Option Exercise | 2,627 | 159.03 | 417,772 | 2025-12-01 16:57:56 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-11-17 | Sell | 3,991 | 380.43 | 1,518,303 | 2025-11-19 16:57:42 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-11-12 | Sell | 16,009 | 365.22 | 5,846,820 | 2025-11-14 17:35:30 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-11-12 | Sell | 996 | 349.17 | 347,770 | 2025-11-14 17:28:24 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-11-12 | Option Exercise | 996 | 191.47 | 190,704 | 2025-11-14 17:28:24 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-10-08 | Sell | 10,671 | 350.40 | 3,739,108 | 2025-10-10 16:56:54 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-10-08 | Option Exercise | 9,559 | 211.04 | 2,017,363 | 2025-10-10 16:56:54 |
| ONC | BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer | 2025-09-16 | Sell | 27,803 | 325.71 | 9,055,694 | 2025-09-18 16:45:14 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-09-10 | Sell | 10,006 | 325.53 | 3,257,289 | 2025-09-12 16:38:35 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-09-10 | Option Exercise | 8,894 | 197.10 | 1,752,981 | 2025-09-12 16:38:35 |
| ONC | BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. | Directior | 2025-09-05 | Sell | 2,665 | 337.00 | 898,105 | 2025-09-09 17:31:54 |
| ONC | BeOne Medicines Ltd. | Sanders Corazon (Corsee) D. | Directior | 2025-09-05 | Option Exercise | 2,665 | 155.68 | 414,887 | 2025-09-09 17:31:54 |
| ONC | BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | 2025-09-02 | Sell | 122 | 326.76 | 39,865 | 2025-09-04 17:29:56 |
| ONC | BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | 2025-09-02 | Sell | 122 | 326.76 | 39,865 | 2025-09-04 17:25:27 |
| ONC | BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | 2025-09-02 | Sell | 122 | 326.76 | 39,865 | 2025-09-04 17:20:07 |
| ONC | BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | 2025-09-02 | Sell | 122 | 326.76 | 39,865 | 2025-09-04 17:20:07 |
| ONC | BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | 2025-09-02 | Sell | 122 | 326.76 | 39,865 | 2025-09-04 17:15:58 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-08-13 | Sell | 89,794 | 304.56 | 27,347,636 | 2025-08-15 16:40:17 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-08-13 | Option Exercise | 89,794 | 160.78 | 14,436,877 | 2025-08-15 16:40:17 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-08-13 | Sell | 11,013 | 300.45 | 3,308,877 | 2025-08-15 16:38:46 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-08-13 | Option Exercise | 8,230 | 177.90 | 1,464,080 | 2025-08-15 16:38:46 |
| ONC | BeOne Medicines Ltd. | Rosenberg Aaron | Chief Financial Officer | 2025-08-01 | Sell | 1,190 | 290.47 | 345,659 | 2025-08-05 17:16:07 |
| ONC | BeOne Medicines Ltd. | Rosenberg Aaron | Chief Financial Officer | 2025-08-01 | Sell | 1,190 | 290.47 | 345,659 | 2025-08-05 17:16:07 |
| ONC | BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | 2025-07-29 | Sell | 4,300 | 302.65 | 1,301,375 | 2025-07-31 17:05:32 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-07-30 | Sell | 920 | 304.60 | 280,233 | 2025-07-31 17:04:05 |
| ONC | BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | 2025-07-18 | Sell | 700 | 300.00 | 210,000 | 2025-07-22 16:54:20 |
| ONC | BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer | 2025-07-09 | Sell | 27,802 | 253.38 | 7,044,591 | 2025-07-11 17:14:15 |
| ONC | BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | 2025-06-23 | Sell | 1,028 | 260.00 | 267,280 | 2025-06-25 17:09:53 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-06-23 | Sell | 1,363 | 260.00 | 354,380 | 2025-06-25 17:08:54 |
| ONC | BeOne Medicines Ltd. | Wang Xiaodong | Directior | 2025-06-24 | Sell | 2,007 | 265.50 | 532,867 | 2025-06-25 17:08:08 |
| ONC | BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer | 2025-06-23 | Sell | 3,174 | 261.61 | 830,360 | 2025-06-25 17:06:35 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-06-16 | Sell | 422 | 266.50 | 112,463 | 2025-06-18 17:12:07 |
| ONC | BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | 2025-06-16 | Sell | 1,647 | 262.11 | 431,699 | 2025-06-18 17:10:46 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-06-16 | Sell | 2,173 | 261.27 | 567,742 | 2025-06-18 17:08:07 |
| ONC | BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer | 2025-06-16 | Sell | 5,140 | 263.33 | 1,353,520 | 2025-06-18 17:06:58 |
| ONC | BeOne Medicines Ltd. | Ball Titus B. | Principal Accounting Officer | 2025-06-10 | Sell | 134 | 258.36 | 34,620 | 2025-06-12 17:51:28 |
| ONC | BeOne Medicines Ltd. | Wang Xiaodong | Directior | 2025-06-10 | Sell | 41,760 | 262.82 | 10,975,316 | 2025-06-12 17:39:37 |
| ONC | BeOne Medicines Ltd. | Wang Xiaodong | Directior | 2025-06-10 | Option Exercise | 41,760 | 6.50 | 271,440 | 2025-06-12 17:39:37 |
| ONC | BeOne Medicines Ltd. | Lee Chan Henry | SVP, General Counsel | 2025-06-06 | Sell | 700 | 256.11 | 179,280 | 2025-06-10 16:57:28 |
| ONC | BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | 2025-06-06 | Sell | 1,402 | 252.39 | 353,853 | 2025-06-10 16:56:19 |
| ONC | BeOne Medicines Ltd. | Wu Xiaobin | President and COO | 2025-06-06 | Sell | 1,934 | 253.15 | 489,591 | 2025-06-10 16:55:12 |
| ONC | BeOne Medicines Ltd. | OYLER JOHN | Chief Executive Officer | 2025-06-06 | Sell | 5,127 | 252.77 | 1,295,946 | 2025-06-10 16:54:03 |
| ONC | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Directior | 2025-02-28 | Sell | 732,827 | 260.00 | 190,535,024 | 2025-02-28 21:28:25 |
